Arena Pharmaceuticals (ARNA)
Create an AlertArena Pharmaceuticals Enterprise Value:
1.499B for June 19, 2013Arena Pharmaceuticals Historical Enterprise Value Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| June 19, 2013 | 1.499B |
| June 18, 2013 | 1.499B |
| June 17, 2013 | 1.497B |
| June 14, 2013 | 1.558B |
| June 13, 2013 | 1.680B |
| June 12, 2013 | 1.689B |
| June 11, 2013 | 1.774B |
| June 10, 2013 | 1.782B |
| June 7, 2013 | 1.756B |
| June 6, 2013 | 1.750B |
| June 5, 2013 | 1.743B |
| June 4, 2013 | 1.771B |
| June 3, 2013 | 1.798B |
| May 31, 2013 | 1.789B |
| May 30, 2013 | 1.802B |
| May 29, 2013 | 1.769B |
| May 28, 2013 | 1.811B |
| May 24, 2013 | 1.672B |
| May 23, 2013 | 1.619B |
| May 22, 2013 | 1.589B |
| May 21, 2013 | 1.604B |
| May 20, 2013 | 1.597B |
| May 17, 2013 | 1.602B |
| May 16, 2013 | 1.606B |
| May 15, 2013 | 1.617B |
| May 14, 2013 | 1.613B |
| May 13, 2013 | 1.597B |
| May 10, 2013 | 1.613B |
| May 9, 2013 | 1.593B |
| May 8, 2013 | 1.647B |
| May 7, 2013 | 1.680B |
| May 6, 2013 | 1.501B |
| May 3, 2013 | 1.525B |
| May 2, 2013 | 1.693B |
| May 1, 2013 | 1.656B |
| April 30, 2013 | 1.658B |
| April 29, 2013 | 1.625B |
| April 26, 2013 | 1.641B |
| April 25, 2013 | 1.678B |
| April 24, 2013 | 1.578B |
| April 23, 2013 | 1.591B |
| April 22, 2013 | 1.597B |
| April 19, 2013 | 1.604B |
| April 18, 2013 | 1.612B |
| April 17, 2013 | 1.617B |
| April 16, 2013 | 1.647B |
| April 15, 2013 | 1.612B |
| April 12, 2013 | 1.652B |
| April 11, 2013 | 1.632B |
| April 10, 2013 | 1.616B |
About Enterprise Value
Click "Learn More" below to see how YCharts calculates Enterprise Value.
Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Learn More
ARNA Enterprise Value Benchmarks
| Companies | |
|---|---|
| Vivus | 1.235B |
| Orexigen Therapeutics | 453.65M |
| ACADIA Pharmaceuticals | 1.358B |
ARNA Enterprise Value Rankings
| Overall |
83rd percentile 2822 of 16782 |
| Sector |
86th percentile 190 of 1410 in Healthcare |
| Industry |
91st percentile 40 of 454 in Biotechnology |
ARNA Enterprise Value Range, Past 5 Years
| Minimum | -22.34M | Nov 18 2010 |
| Maximum | 2.227B | Jun 21 2012 |
| Average | 531.79M |
